IP Library Granted Patent US 8,568,312
Granted Patent B2
US 8,568,312 · App. 12/661,240 · Granted Oct 29, 2013

Electro diagnostic functional assessment unit (EFA-3)

Inventors: MaryRose Cusimano Reaston (Las Vegas, NV); Phil Reaston (Las Vegas, NV)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,568,312
App. No.
12/661,240
Granted
Oct 29, 2013
Kind
B2
Abstract

An Electro Diagnostic Functional Assessment Unit (EFA-3) that is designed to wirelessly monitor muscle group activity and to provide treatment for humans and animals. The muscle groups include the body, fascial, cervical, thoracic, upper and lower extremities, lumbosacral, bladder, cardiac, and rectal. In large animals the muscle groups include torso, legs, neck and face. The EFA-3 simultaneously correlates the muscle activity EMG with cardiac activity, nerve activity, heart rate, blood flow and brain activity with range-of-motion, grip and pinch assessment and a functional assessment in humans. The EFA-3 is operated by proprietary software ( 78 ) which provides testing protocols by utilizing a set of wireless sensor(s) ( 14 - 40 ) that are interchangeable and rechargeable. The treatment includes ultrasound, heat, cold, massage and electrical stimulation.

Claims (16)

1. An electro diagnostic functional assessment unit (EFA-3) comprising:

a) a data transmitting unit comprising a plurality of wireless sensors, that monitor EMG, EKG, nerve conduction velocity (NCV) with rang of motion (ROM), functional capacity evaluation (FCE), and pinch or grip, wherein said sensors function together to derive specific data, wherein each sensor has an input and an output, wherein the input is attached to a selected area of a subject that is undergoing a testing protocol, wherein said sensors provide the data pertaining to the EMG, EKG, NCV with ROM, FCE, and pinch or grip, wherein the acquired data in combination are used to provide site-specific treatment with said EFA-3,

b) a receiving and transmitting interface that utilizes a wireless system having means for receiving the output from said wireless sensors for the EMG, EKG, FCE, NCV with ROM, and pinch or grip and producing an output that is applied to said sensors for providing site-specific treatment, and

c) a data receiving unit comprising =a treatment delivery mechanism for delivering site-specific treatment that is selected from the group consisting of ultrasound, electrical stimulation, heat, cold, and massage that is performed from the information derived from the combined use of the EMG, EKG, NCV with ROM, FCE, and pinch or grip.

2. The EFA-3 as specified in claim 1 wherein said plurality of wireless sensors comprise:

a) at least one EMG sensor,

b) at least one EKG sensor,

c) at least one rang-of-motion (ROM) sensor,

d) at least one functional capacity evaluation (FCE) sensor,

e) at least one grip sensor,

f) at least one pinch sensor, and

g) at least one treatment delivery mechanism.

3. An electro diagnostic functional assessment unit (EFA-3) comprising:

a) a plurality of wireless sensors, wherein said sensors each have an input and an output, wherein the input is attached to a selected area of a subject that is undergoing a testing protocol, wherein said sensors provide data pertaining to EMG, EKG, nerve conduction velocity (NCV) with range of motion (ROM), functional capacity evaluation (FCE), and pinch or grip, which are used in combination to provide site-specific treatment with said EFA-3,

b) a data acquisition circuit having means for receiving and processing the output from said plurality of wireless sensors and producing an output that delivers site-specific treatment based on the data derived in combination from the EMG, EKG, nerve conduction velocity (NCV) with range of motion (ROM), functional capacity evaluation (FCE), and pinch or grip, and

c) a treatment delivery mechanism for delivering a site-specific treatment that is selected from the group consisting of ultrasound, electrical stimulation, heat, cold, and message used with said EFA-3.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 22, 2024
From: WESTERN ALLIANCE BANK
To: EMERGE DIAGNOSTICS INC.
Reel/Frame 067184/0920 →
SECURITY INTEREST Recorded May 9, 2018
From: EMERGE DIAGNOSTICS, INC.
To: WESTERN ALLIANCE BANK, AN ARIZONA CORPORATION
Reel/Frame 045755/0034 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2018
From: OKTX LLC
To: EMERGE DIAGNOSTICS
Reel/Frame 045732/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2013
From: IDI-DX, INC., F/K/A INSIGHT DIAGNOSTICS, INC.
To: OKTX, LLC
Reel/Frame 029993/0677 →
CHANGE OF NAME Recorded Nov 9, 2011
From: INSIGHT DIAGNOSTICS, INC.
To: IDI-DX, INC.
Reel/Frame 027203/0626 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2010
From: CUSIMANO-REASTON, MARYROSE; REASTON, PHIL
To: INSIGHT DIAGNOSTICS INC.
Reel/Frame 025453/0884 →
Continuity (1)
Related Publication 20110224503A1 · Sep 15, 2011